Lens Opacity in ABCA4-Associated Stargardt Disease Patients in the ProgStar Study
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.8.47 ↗At a glance
Multizentrische Studie in Investigative Ophthalmology & Visual Science, 2026. Written by Folahan Ibukun and 14 co-authors. Institution: Wilmer Eye Institute, Johns Hopkins Medicine, Baltimore, Maryland, United States. Major MEDLINE topics: ATP-Binding Cassette Transporters, Cataract, Macular Degeneration. 44 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS.
Abstract (original language)
Purpose
The purpose of this study was to estimate lens opacity (LO) and associated risk factors in patients with ABCA4 associated Stargardt disease (STGD1).
Methods
This is a secondary analysis of the multicenter ProgStar study. Patients with molecularly confirmed STGD1 aged ≥6 years from the United States and Europe were enrolled and followed for 2 years. LO was graded using the Age-Related Eye Disease Study (AREDS) protocol during slit lamp examinations. Baseline prevalence and 2-year incidence of LO were estimated. Logistic regression with generalized estimating equation was used to identify risk factors associated with LO.
Results
Of the 259 participants, 54% were women, 86% were Caucasian, and the median age of STGD1 symptom onset was 19 years. At baseline, median age = 31 (interquartile range [IQR] = 21-44, range = 6-68) years; LO prevalence = 14.3% (69/483) of study eyes. Older age and later disease symptom onset were significantly associated with LO prevalence: for every decade older, adjusted odds ratio (adjOR) = 4.6 (95% confidence interval [CI] = 2.6-7.9); adjOR for every decade later in symptom onset = 0.7 (95% CI = 0.4-1.0). Among the 354 eyes without LO at baseline, 2-year incidence was 5.6%. Older age was associated with incidence: adjOR for every decade older = 4.1 (95% CI = 1.8-9.1). Posterior-subcapsular cataract was rare and nuclear cataract was the most prevalent or incident type.
Conclusions
LO prevalence in ProgStar is higher than in age-matched general population. Age and age of symptom onset were risk factors of LO, suggesting both biological and accelerated aging due to retinal degeneration in STGD1. Trials of STGD1 should closely monitor safety in the anterior segment and consider excluding patients expecting cataract surgery soon.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Wilmer Eye Institute, Johns Hopkins Medicine, Baltimore, Maryland, United States.
- Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States.
- University of Tuebingen, Tübingen, Baden-Württemberg, Germany.
- Medical University of Graz, Graz, Styria, Austria.
- Moorfields Eye Hospital, London, England, United Kingdom.
- Retina Foundation of the Southwest, Dallas, Texas, United States.
Funding
- NEI NIH HHS
Cite
APA
Ibukun, F., Chan, B. X. J., Khan, J., Wang, Y., Ervin, A. M., Kühlewein, L., Strauss, R. W., Aychoua, N., Birch, D., Cideciyan, A., Singh, M., Traboulsi, E., Bernstein, P., Michaelides, M., & Kong, X. (2026). Lens Opacity in ABCA4-Associated Stargardt Disease Patients in the ProgStar Study. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.8.47
Vancouver
Ibukun F, Chan BXJ, Khan J, Wang Y, Ervin AM, Kühlewein L, et al. Lens Opacity in ABCA4-Associated Stargardt Disease Patients in the ProgStar Study. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.8.47
BibTeX
@article{Ibukun2026,
author = {Ibukun, Folahan and Chan, Bai Xi Jasmine and Khan, Jehanzeb and Wang, Yan and Ervin, Ann-Margret and Kühlewein, Laura and Strauss, Rupert W and Aychoua, Nancy and Birch, David and Cideciyan, Artur and Singh, Mandeep and Traboulsi, Elias and Bernstein, Paul and Michaelides, Michel and Kong, Xiangrong},
title = {Lens Opacity in ABCA4-Associated Stargardt Disease Patients in the ProgStar Study},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.8.47}
}
EUVIMED